CRMD

Steven W. Lefkowitz

CIK: 0001313149

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

CRMD: No direct news in the last week. Recent headlines involve Actinium Pharmaceuticals, not CorMedix Inc. There are no events that directly affect CRMD’s operations or market position. Investors can continue to monitor CRMD’s own performance and broader market conditions.

this person other insiders at CRMD

Transaction History

CRMD▲ Buy$0
CRMD▲ Buy$84K
CRMD▼ Sell$475K
CRMD▲ Buy$81K
CRMD▲ Buy$0
CRMD▲ Buy$34K

We use analytics to understand how market-wall is used. No personal data is sold.